Skip to main content
. Author manuscript; available in PMC: 2021 May 5.
Published in final edited form as: Hypertension. 2021 Mar 29;77(5):1591–1599. doi: 10.1161/HYPERTENSIONAHA.120.16454

Figure 1. Change in the forearm blood flow ratio (infused/ control arm).

Figure 1

FBF responses to Acetylcholine (panel A), Sodium nitroprusside (panel B), and NG-monomethyl-L-arginine (panel C) at baseline (blue line), at 2 weeks after initiation of pazopanib (red line) and at 12 weeks (green line) or when subject became hypertensive (Visit HYP). * denotes P<0.001 (a hierarchical mixed effects model). Data are expressed as a geometric mean FBF ratio (infused to control arm) ± SEM.